2022
DOI: 10.1002/mus.27498
|View full text |Cite
|
Sign up to set email alerts
|

The value of MUNIX as an objective electrophysiological biomarker of disease progression in chronic inflammatory demyelinating polyneuropathy

Abstract: Introduction/Aims: Objective outcome measures to monitor treatment response and guide treatment are lacking in chronic inflammatory demyelinating polyneuropathy (CIDP). In this study we aimed to evaluate the motor unit number index (MUNIX) as an outcome measurement in patients with CIDP and determine the correlation of MUNIX with functional and standard electrodiagnostic tests in a single follow-up study. Methods: We evaluated MUNIX of the abductor pollicis brevis, abductor digiti minimi, and tibialis anterior… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…Demonstration of axonal loss of sensory and motor fibers was proved using sural nerve biopsy [ 32 ] and neurophysiological tolls, such as motor unit number estimation (MUNE) and motor unit number index (MUNIX), that were both decreased in CIDP patients [ 13 , 33 , 34 ]. Despite clinical and neurophysiological improvement, residual alterations of nerve conduction parameters after ScIg treatment for 24 months (increased DML and reduced CMAP amplitude and area), in the absence of demyelinating features (conduction blocks and temporal dispersion), suggest an axonal degeneration process [ 35 ].…”
Section: Discussionmentioning
confidence: 99%
“…Demonstration of axonal loss of sensory and motor fibers was proved using sural nerve biopsy [ 32 ] and neurophysiological tolls, such as motor unit number estimation (MUNE) and motor unit number index (MUNIX), that were both decreased in CIDP patients [ 13 , 33 , 34 ]. Despite clinical and neurophysiological improvement, residual alterations of nerve conduction parameters after ScIg treatment for 24 months (increased DML and reduced CMAP amplitude and area), in the absence of demyelinating features (conduction blocks and temporal dispersion), suggest an axonal degeneration process [ 35 ].…”
Section: Discussionmentioning
confidence: 99%